In bladder cancer, progranulin binds to and triggers EphA2 tyrosine-phosphorylation, with consequent activation of the AKT and MAPK signaling pathways, which in turn promote EphA2 phosphorylation at Ser 897 [59,129] (Figure 2). This evidence concerns the gene GRN and urinary bladder carcinoma.